CLYMClimb Bio Inc
$10.86+558% 1Y
$10.86
$1.6452 weeks$17.83
CLYM as reported
- Net income
- −$58M
Net income · +23% year on year · trailing twelve months to Q2 2026
- EPS
- −$0.82
EPS · +55% year on year · trailing twelve months to Q2 2026
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Net income | −$58M | +23% | Q2 2026 |
| EPS | −$0.82 | +55% | Q2 2026 |
| ROE | −31% | n/a | Q2 2026 |
| ROA | −30% | n/a | Q2 2026 |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Climb Bio Inc (CLYM) · Net incomeNet incomeClimb Bio Inc (CLYM)